Arvinas, Inc. (ARVN)
11.96
+0.23
(+1.96%)
USD |
NASDAQ |
Dec 31, 15:44
Arvinas Market Cap: 768.12M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 141.72B |
| Alnylam Pharmaceuticals, Inc. | 53.00B |
| Verastem, Inc. | 582.98M |
| Sarepta Therapeutics, Inc. | 2.278B |
| Genprex, Inc. | 1.778M |
Market Cap Related Metrics
| PS Ratio | 2.786 |
| Price to Book Value | 1.361 |
| Price | 11.96 |
| Earnings Yield | -6.71% |